Tesla Model Y
11Feb

Tesla Stock Is Popping, But Here’s Why These Hedge Funds Are Short

Tesla has proven to be one of the most divisive stocks over the years, driven by the tension between CEO Elon Musk and the many well-known investors who are shorting it. Multiple hedge funds highlighted their Tesla positions in their recent letters to investors, and perhaps unsurprisingly, those who are talking about the stock are shorting it. At least one firm suggested the EV maker may even be engineering its financials.

Sign up here

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click chat

Author

Michelle Jones was a television news producer for eight years. She produced the morning news programs for the NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spent a short time at the CBS affiliate in Huntsville. She has experience as a writer and public relations expert for a wide variety of businesses.

Related Posts

Carbon Emissions
22Mar

Current Carbon Emissions Worse Than Any Point In World History

By

There is an event that has not happened in 66 million years – a point in time that carbon was put into the atmosphere and resulted in major “kills”... read more

Billabong International Logo
05Jul

Billabong’s New Lenders Oaktree, Centerbridge Hire Moelis & Co

By

Billabong International Limited (ASX:BBG)’s new lenders, the U.S. hedge funds, have hired global investment bank Moelis & Co as an advisor, according to The Wall Street Journal. The U.S. hedge... read more

annual price performance JPM 113
29Nov

S&P 500 Up 26 Percent, But This Is An “Ordinary” Rally: JPMorgan

By

The S&P 500 (INDEXSP:.INX) is up 26% year to date, and most people agree that the market has had a tremendous year, but according to historical analysis from JPMorgan Chase... read more

salix pharmaceuticals
19Dec

Paulson Acquires Stake In Salix Amid Inventory Pileup Concerns

By

Famous investment firm Paulson & Co has acquired an undisclosed stake in Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) as the drug maker recovers from inventory pileup issues and the exit of its... read more

Hedge Funds
02Jan

Average Investor Outperforms Hedge Funds In 2013

By

The three major indices have outshone hedge funds during 2013. The DJIA closed 2013 with a gain of 26.5%, the S&P 500 (INDEXSP:.INX) was up 29.6% and the Nasdaq... read more

13Jun

Euro Weakness No Longer A Headline Problem

By

As the cycle of European crises becomes shorter and shorter the problem has ceased to be one of headline risk according to a report from Deutsche Bank AG (NYSE:DB).... read more

Yahoo
15Jul

Yahoo! Earnings Preview: Boom Or Bust?

By

Yahoo! Inc. (NASDAQ:YHOO) is due to reveal its earnings for the second quarter of 2013 on Tuesday July 16 after the market closes. The market is optimistic given the... read more

Brazil in sweet spot
18Aug

Brazil Gets Some Breathing Room From Rating Agencies: Barclays

By

Despite ratings agency S&P recently changing its outlook on Brazil to negative, Moody’s has positively surprised by changing its outlook to stable, thereby providing some breathing room to Brazil,... read more

27Dec

BOA: Expect A Technical Stock Market Rally During Q1 2017

By

Technical Stock Market Rally ahead? No one knows the future but people especially banks like to think they do and at least one believes this is the case for... read more

Russell 2000 driven by biotech 0314
04Mar

Russell 2000 Bull Run Led Almost Entirely By Biotech/Pharma

By

The Russell 2000 (INDEXRUSSELL:RUT) is up 2.2% last week, beating out the Russell Midcap (INDEXRUSSELL:RMCC) and S&P 500 (INDEXSP:.INX). Consumer discretionary was the best performing sector for the week, but year-to-date... read more

X
Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Are you an intelligent investor?

ValueWalkPremium is a website and newsletter for smart investors like yourself. We focus on the latest hedge fund industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers

0